Evidence map›Paper›PMID 28834608›Full record

Trial reportAddiction (Abingdon, England)2017

Accuracy of self-reported smoking abstinence in clinical trials of hospital-initiated smoking interventions.

Taneisha S Scheuermann, Kimber P Richter, Nancy A Rigotti, Sharon E Cummins, Kathleen F Harrington, Scott E Sherman, Shu-Hong Zhu, Hilary A Tindle, Kristopher J Preacher, Consortium of Hospitals Advancing Research on Tobacco (CHART)

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Addiction (Abingdon, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. A Scoping Review and Meta-analysis of the Use of Remote Biochemical Verification Methods of Smoking Status in Tobacco Research.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. A Randomized Controlled Trial of an Optimized Smoking Treatment Delivered in Primary Care.Annals of behavioral medicine : a publication of the Society of Behavioral Medicine · 2018
    Trial
  11. Trial
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Observational
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Taneisha S ScheuermannDepartment of Preventive Medicine and Public Health, University of Kansas School of Medicine, Kansas City, KS, USA.ORCID http://orcid.org/0000-0001-9543-903X
Kimber P RichterDepartment of Preventive Medicine and Public Health, University of Kansas School of Medicine, Kansas City, KS, USA.
Nancy A RigottiTobacco Research and Treatment Center, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
Sharon E CumminsDepartment of Family Medicine and Public Health, and Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
Kathleen F HarringtonDivision of Pulmonary, Allergy, and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Scott E ShermanDepartment of Population Health, New York University School of Medicine, New York, NY, USA.
Shu-Hong ZhuDepartment of Family Medicine and Public Health, and Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.
Hilary A TindleVanderbilt Center for Tobacco, Addictions, and Lifestyle, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Kristopher J PreacherDepartment of Psychology and Human Development, Vanderbilt University, Nashville, TN, USA.
Consortium of Hospitals Advancing Research on Tobacco (CHART)

Funding

Comparative Effectiveness of Post-Discharge Strategies for Hospitalized SmokersR01HL111821 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI RIGOTTI, NANCY A, TINDLE, HILARY A. · 2012 to 2021
$8.4M
Effectiveness of smoking-cessation interventions for urban hospital patientsU01HL105229 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SHERMAN, SCOTT E · 2010 to 2014
$5.1M
Web-based Smoking Cessation Intervention: transition from inpatient to outpatientU01DA031515 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HARRINGTON, KATHY F · 2010 to 2013
$4.0M
Inpatient Technology-Supported Assisted ReferralU01HL105231 · NHLBI · KAISER FOUNDATION RESEARCH INSTITUTE · PI FELLOWS, JEFFREY L · 2010 to 2013
$3.7M
Increasing Post-discharge Follow Up among Hospitalized SmokersU01HL105232 · NHLBI · UNIVERSITY OF KANSAS MEDICAL CENTER · PI RICHTER, KIMBER P · 2010 to 2013
$2.9M
Dissemination of Tobacco Tactics versus 1-800-QUIT-NOW for Hospitalized SmokersU01HL105218 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DUFFY, SONIA A · 2010 to 2012
$2.8M
Using NRT and Quitline Services to Help Hospitalized Smokers Stay QuitU01CA159533 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZHU, SHU-HONG · 2010 to 2013
$2.5M
Smoking Interventions for Hospital Patients:A Comparative Effectiveness TrialRC1HL099668 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI RIGOTTI, NANCY A · 2009 to 2010
$996k
NCI NIH HHS U01 CA159533NHLBI NIH HHS R01 HL111821NHLBI NIH HHS RC1 HL099668NHLBI NIH HHS U01 HL105218NHLBI NIH HHS U01 HL105229NHLBI NIH HHS U01 HL105231NHLBI NIH HHS U01 HL105232NIDA NIH HHS U01 DA031515
6 · The paper itself

Abstract

aimsTo estimate the prevalence and predictors of failed biochemical verification of self-reported abstinence among participants enrolled in trials of hospital-initiated smoking cessation interventions.

designComparison of characteristics between participants who verified and those who failed to verify self-reported abstinence. SETTINGS: Multi-site randomized clinical trials conducted between 2010 and 2014 in hospitals throughout the United States.

participantsRecently hospitalized smokers who reported tobacco abstinence 6 months post-randomization and provided a saliva sample for verification purposes (n = 822). MEASUREMENTS: Outcomes were salivary cotinine-verified smoking abstinence at 10 and 15 ng/ml cut-points. Predictors and correlates included participant demographics and tobacco use; hospital diagnoses and treatment; and study characteristics collected via surveys and electronic medical records.

findingsUsable samples were returned by 69.8% of the 1178 eligible trial participants who reported 7-day point prevalence abstinence. The proportion of participants verified as quit was 57.8% [95% confidence interval (CI) = 54.4, 61.2; 10 ng/ml cut-off] or 60.6% (95% CI = 57.2, 63.9; 15 ng/ml). Factors associated independently with verification at 10 ng/ml were education beyond high school education [odds ratio (OR) = 1.51; 95% CI = 1.07, 2.11], continuous abstinence since hospitalization (OR = 2.82; 95% CI = 2.02, 3.94), mailed versus in-person sample (OR = 3.20; 95% CI = 1.96, 5.21) and race. African American participants were less likely to verify abstinence than white participants (OR = 0.64; 95% CI = 0.44, 0.93). Findings were similar for verification at 15 ng/ml. Verification rates did not differ by treatment group.

conclusionsIn the United States, high rates (40%) of recently hospitalized smokers enrolled in smoking cessation trials fail biochemical verification of their self-reported abstinence.

Indexed as

Clinical Trials as TopicHospitalsSelf ReportAdolescentAdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedProgram EvaluationReproducibility of ResultsSmoking CessationYoung AdultBiochemical verificationhospital patientssaliva cotinineself-reportsmoking cessationtrials

Identifiers

PMID28834608
PMCPMC5673569

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.